No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Cyclin-Dependent Kinase Inhibitor p15 / deficiency
-
Cyclin-Dependent Kinase Inhibitor p15 / genetics*
-
Cyclin-Dependent Kinase Inhibitor p16 / deficiency
-
Cyclin-Dependent Kinase Inhibitor p16 / genetics*
-
Drug Resistance, Neoplasm*
-
Fatal Outcome
-
Gene Deletion
-
Gene Expression
-
Humans
-
Immunoglobulins / genetics*
-
Interferon Regulatory Factors / genetics*
-
Lymphoma, Large B-Cell, Diffuse / drug therapy
-
Lymphoma, Large B-Cell, Diffuse / genetics*
-
Lymphoma, Large B-Cell, Diffuse / pathology
-
Male
-
Middle Aged
Substances
-
Antineoplastic Agents
-
CDKN2B protein, human
-
Cyclin-Dependent Kinase Inhibitor p15
-
Cyclin-Dependent Kinase Inhibitor p16
-
IgK
-
Immunoglobulins
-
Interferon Regulatory Factors
-
interferon regulatory factor-4